Tablo Demonstrates High Treatment Completion Among Users
A perennial concern of nephrologists who are not familiar with home HD is that patients at home won’t do their treatments. Results of a new trial with the Outset Tablo should ease their minds. The study found that treatment adherence was 95%, with 92% of treatments completing at least 90% of the prescribed time.
Read the full article » | Posted 11-16-2022
Related Articles
- Roshanda Switched from In-center HD to PD to Home HD Posted 03-15-2024
- Regan has Down Syndrome, Type I Diabetes, and Kidney Failure Posted 03-15-2024
- Raymond Scott Began His Kidney Failure Journey at 29. Now He is 54 Posted 03-15-2024
- Christina Gilchrist Wouldn’t Take No for an Answer Posted 03-15-2024